Frazier Life Sciences Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,118,051
| Closed | -$8.58M | – | 55 |
|
|
2023
Q4 | $8.58M | Sell |
2,118,051
-130,143
| -6% | -$527K | 0.46% | 43 |
|
|
2023
Q3 | $6.05M | Hold |
2,248,194
| – | – | 0.4% | 41 |
|
|
2023
Q2 | $21M | Hold |
2,248,194
| – | – | 1.25% | 19 |
|
|
2023
Q1 | $20M | Buy |
2,248,194
+850,000
| +61% | +$7.55M | 1.45% | 18 |
|
|
2022
Q4 | $6.96M | Buy |
+1,398,194
| New | +$6.96M | 0.43% | 37 |
|